Range
- - -
Vol / Avg.
-/9K
Div / Yield
-
52 Wk
0.01 - 0.3
Mkt Cap
11.5M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.01
Shares
57.5M
Outstanding
-
Total Float
-
There is no Press for this Ticker
Hemostemix Inc is a clinical-stage biotechnology company. Its principal business activity is to develop, manufacture, and commercialize blood-derived cell therapies for medical conditions. The company's technology platform for developing autologous cell therapies is for the treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia.

Related Companies

TickerCompanyChg %Mkt Cap
HMTXFHemostemix0%11.5M

Hemostemix Frequently Asked Questions

Q

How do I buy Hemostemix (HMTXF) stock?

A

You can purchase shares of Hemostemix (OTC: HMTXF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Hemostemix's (HMTXF) competitors?

A

There are no as such competitors for Hemostemix.

Q

What is the target price for Hemostemix (HMTXF) stock?

A

There is no analysis for Hemostemix

Q

Current Stock Price for Hemostemix (HMTXF)?

A

The stock price for Hemostemix (OTC: HMTXF) is $0.1997 last updated Fri Jul 30 2021 13:49:48 GMT+0000 (Coordinated Universal Time).

Q

Does Hemostemix (HMTXF) pay a dividend?

A

There are no upcoming dividends for Hemostemix.

Q

When is Hemostemix (OTC:HMTXF) reporting earnings?

A

Hemostemix does not have any upcoming earnings scheduled.

Q

Is Hemostemix (HMTXF) going to split?

A

There is no upcoming split for Hemostemix.

Q

What sector and industry does Hemostemix (HMTXF) operate in?

A

Hemostemix is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.